The Raf/MEK/ERK signal transduction cascade as a target for chemotherapeutic intervention in leukemia
- 1 April 2002
- journal article
- review article
- Published by Springer Science and Business Media LLC in Leukemia
- Vol. 16 (4), 486-507
- https://doi.org/10.1038/sj.leu.2402460
Abstract
The Raf/MEK/ERK (MAPK) signal transduction cascade is a vital mediator of a number of cellular fates including growth, proliferation and survival, among others. The focus of this review centers on the MAPK signal transduction pathway, its mechanisms of activation, downstream mediators of signaling, and the transcription factors that ultimately alter gene expression. Furthermore, negative regulators of this cascade, including phosphatases, are discussed with an emphasis placed upon chemotherapeutic intervention at various points along the pathway. In addition, mounting evidence suggests that the PI3K/Akt pathway may play a role in the effects elicited via MAPK signaling; as such, potential interactions and their possible cellular ramifications are discussed.Keywords
This publication has 97 references indexed in Scilit:
- Structure−Activity Relationships for 5-Substituted 1-Phenylbenzimidazoles as Selective Inhibitors of the Platelet-Derived Growth Factor ReceptorJournal of Medicinal Chemistry, 1999
- Induction of NF-κB by the Akt/PKB kinaseCurrent Biology, 1999
- Negative Regulation of PKB/Akt-Dependent Cell Survival by the Tumor Suppressor PTENCell, 1998
- In VitroInhibition of Ras–Raf Association by Short PeptidesBiochemical and Biophysical Research Communications, 1998
- Activation Mechanism of the MAP Kinase ERK2 by Dual PhosphorylationCell, 1997
- Role of Protein Phosphatase 2A in the Regulation of Mitogen-Activated Protein Kinase Activity in Ventricular CardiomyocytesBiochemical and Biophysical Research Communications, 1996
- Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitorNature, 1996
- Oncogene activation: c-raf-1 gene mutations in experimental and naturally occurring tumorsToxicology Letters, 1993
- Transformation suppressor activity of a Jun transcription factor lacking its activation domainNature, 1991
- ERKs: A family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGFCell, 1991